-
-
-
-
-
-
-
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
-
-
-
-
-
-
-
OPKO Health (OPK) Misses Q2 EPS by 8c
-
-
-
-
-
-
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
-
-
-
-
-
-
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
-
-
-
-
-
-
-
OPKO Health (OPK) Misses Q1 EPS by 2c
-
-
-
-
-
-
-
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
-
-
-
-
-
-
-
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
-
1,197,297 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

